Overview

Coenzyme Q10 for Gulf War Illness: A Replication Study

Status:
RECRUITING
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.
Phase:
PHASE3
Details
Lead Sponsor:
University of California, San Diego
Collaborator:
United States Department of Defense